期刊
IMMUNITY
卷 47, 期 6, 页码 1037-+出版社
CELL PRESS
DOI: 10.1016/j.immuni.2017.11.001
关键词
-
类别
资金
- CONACyT (Mexico) [237333]
- Stanford Medicine Dean's Office
- NSF GRFP fellowship [DGE-1147470]
- NIH [1DP2AR069953, R01AI118884, U19AI057229, P30 CA124435]
- Baxter Foundation
- Freidenrich Foundation
- [S10RR025518]
- [S10OD016318]
Given the limited efficacy of clinical approaches that rely on ex vivo generated dendritic cells (DCs), it is imperative to design strategies that harness specialized DC subsets in situ. This requires delineating the expression of surfacemarkers by DC subsets among individuals and tissues. Here, we performed a multi-parametric phenotypic characterization and unbiased analysis of human DC subsets in blood, tonsil, spleen, and skin. We uncovered previously unreported phenotypic heterogeneity of human cDC2s among individuals, including variable expression of functional receptors such as CD172a. We found marked differences in DC subsets localized in blood and lymphoid tissues versus skin, and a striking absence of the newly discovered Axl(+) DCs in the skin. Finally, we evaluated the capacity of anti-receptor monoclonal antibodies to deliver vaccine components to skin DC subsets. These results offer a promising path for developing DC subset-specific immunotherapies that cannot be provided by transcriptomic analysis alone.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据